how is semaglutide different from tirzepatide vs. Semaglutide: What's the Difference? Semaglutide vs. Tirzepatide vs. Retatrutide

Oral Semaglutide at a Dose of 25mg in Adults with Overweight or Obesity

Endocrine Connections, 14(5), e240529

Patients with non-alcoholic fatty liver disease may actually benefit from GLP-1 receptor agonists, as clinical studies show these medications can reduce liver fat content and improve liver enzyme levels

As the sector matures, the focus has apparently shifted from first-generation GLP-1 therapies toward differentiated approaches, including oral formulations, less frequent dosing schedules, improved body-composition outcomes such as lean muscle preservation, and next-generation mechanisms that combine GLP-1 with complementary pathways such as GIP, glucagon, and amylin

or oral administration